Molnupiravir
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-135853-5MG | 5 mg | 70,00 | Add | |
| HY-135853-10MG | 10 mg | 102,00 | Add | |
| HY-135853-1ML | 10mM/1mL | 111,00 | Add | |
| HY-135853-25MG | 25 mg | 128,00 | Add | |
| HY-135853-50MG | 50 mg | 204,00 | Add | |
| HY-135853-100MG | 100 mg | 330,00 | Add | |
| HY-135853-200MG | 200 mg | 584,00 | Add | |
| HY-135853-500MG | 500 mg | 1'217,00 | Add | |
| HY-135853-1G | 1 g | 1'977,00 | Add | |
| HY-135853-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Infection, Anti-infection |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic);H2O : 12.5 mg/mL (ultrasonic) |
| Grade | Clinical information: Launched |
| Purity | 99.94% |
| Molecular Formula | C13H19N3O7 |
| Molecular Weight | 329.31 |
| CAS-Number | 2492423-29-5 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
